VA BENEFITS REFERENCE
The Respiratory System: Shared Criteria For DC 6834 Through 6839
Read the respiratory system criteria for DC 6834 through 6839: 6 listed codes, their distinct instructions, shared formulas and official notes.
Published criteria from 38 CFR 4.97, current through 2026-10-22. Historical decisions may require a different version. This reference does not diagnose a condition or determine an evaluation.
The Respiratory System · All Diagnostic Codes
DC 6834: Histoplasmosis Of Lung
Diagnostic code 6834 addresses Histoplasmosis of lung. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6834 Histoplasmosis of lung. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6834, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
DC 6835: Coccidioidomycosis
Diagnostic code 6835 addresses Coccidioidomycosis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6835 Coccidioidomycosis. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6835, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
DC 6836: Blastomycosis
Diagnostic code 6836 addresses Blastomycosis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6836 Blastomycosis. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6836, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
DC 6837: Cryptococcosis
Diagnostic code 6837 addresses Cryptococcosis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6837 Cryptococcosis. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6837, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
DC 6838: Aspergillosis
Diagnostic code 6838 addresses Aspergillosis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6838 Aspergillosis. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6838, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
DC 6839: Mucormycosis
Diagnostic code 6839 addresses Mucormycosis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.
| Rating | |
|---|---|
| 6839 Mucormycosis. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Read the shared provisions referenced by this code: Mycotic Lung Formula.
What The Criteria Measure
- Does the decision identify diagnostic code 6839, and does the medical record describe the condition named by this code?
- Are the required clinical measurements, testing methods and any stated exceptions documented by a qualified clinician?
- Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
- Have the code-specific notes and cross-references been read before comparing any listed evaluation?
Related Public DBQs
Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.
Regulatory Cross-References
Mycotic Lung Formula
Referenced by DC 6834, DC 6835, DC 6836, DC 6837, DC 6838, DC 6839. Apply only as each code directs, including its conditions and exceptions.
| Rating | |
|---|---|
| General Rating Formula for Mycotic Lung Disease (diagnostic codes 6834 through 6839): | |
| Chronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis | 100 |
| Chronic pulmonary mycosis requiring suppressive therapy with no more than minimal symptoms such as occasional minor hemoptysis or productive cough | 50 |
| Chronic pulmonary mycosis with minimal symptoms such as occasional minor hemoptysis or productive cough | 30 |
| Healed and inactive mycotic lesions, asymptomatic | 0 |
| Note: Coccidioidomycosis has an incubation period up to 21 days, and the disseminated phase is ordinarily manifest within six months of the primary phase. However, there are instances of dissemination delayed up to many years after the initial infection which may have been unrecognized. Accordingly, when service connection is under consideration in the absence of record or other evidence of the disease in service, service in southwestern United States where the disease is endemic and absence of prolonged residence in this locality before or after service will be the deciding factor. | |
| 1 Review for entitlement to special monthly compensation under § 3.350 of this chapter. | |
Shared Rules And Regulatory Context
Context provisions do not create an additional evaluation automatically assigned to every condition.
Related Guides
Official Sources
Last verified 2026-10-25. Source publication or legal effective dates are shown separately where available.
Check The Source. Get Accredited Help.
Use this resource to understand published information. VA and the official decision control individual benefits.